6472 — Bora Pharmaceuticals Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Bora Pharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,529	1,800	4,900	10,494	14,200
Cost of Revenue
Gross Profit	643	704	1,672	2,913	6,991
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	1,184	1,186	3,854	8,572	8,951
Operating Profit	345	614	1,046	1,922	5,249
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	325	595	1,024	1,840	4,064
Provision for Income Taxes
Net Income After Taxes	305	578	750	1,402	3,072
Minority Interest
Net Income Before Extraordinary Items
Net Income	305	578	750	1,392	3,030
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	305	578	750	1,395	3,044
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.37	2.09	7.72	14.1	29.4
Dividends per Share